Al­ler­gan set to make head­way in crowd­ed CGRP mi­graine mar­ket, as the bat­tle for for­mu­la­ry cov­er­age be­gins

Mil­lions of mi­graine suf­fer­ers could soon get their hands on an oral CGRP drug de­signed to be used as-need­ed, as Al­ler­gan $AGN on Wednes­day said …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.